We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Benchmark Holdings Plc | LSE:BMK | London | Ordinary Share | GB00BGHPT808 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.85 | -1.89% | 44.15 | 43.80 | 44.50 | 44.00 | 44.00 | 44.00 | 25,000 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 169.74M | -23.15M | -0.0313 | -14.06 | 325.32M |
28 March 2024
Benchmark Holdings plc
("Benchmark" or "the Company")
Total Voting Rights
In accordance with the FCA's Disclosure and Transparency Rules, the Company wishes to notify the market of the following:
As of 28 March 2024, the Company's issued share capital consisted of 739,551,970 ordinary shares of 0.1 pence each ("Ordinary Shares"), all with voting rights. No shares are currently held in treasury. The total number of voting rights in the Company as of 28 March 2024 is therefore 739,551,970.
The above figure (739,551,970 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company.
Benchmark Holdings plc |
benchmark@mhpc.com |
Trond Williksen, CEO |
|
Septima Maguire, CFO |
|
Ivonne Cantu, Investor Relations |
|
|
|
Deutsche Numis (Broker and NOMAD) |
Tel: +44 (0) 20 7260 1000 |
Freddie Barnfield / Duncan Monteith/ Sher Shah |
|
|
|
MHP |
|
Katie Hunt/Reg Hoare |
Tel: +44 (0) 20 3128 8100 benchmark@mhpc.com |
1 Year Benchmark Chart |
1 Month Benchmark Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions